171 related articles for article (PubMed ID: 22775584)
1. Desmin and CD34 positivity in cellular fibrous histiocytoma: an immunohistochemical analysis of 100 cases.
Volpicelli ER; Fletcher CD
J Cutan Pathol; 2012 Aug; 39(8):747-52. PubMed ID: 22775584
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Sachdev R; Sundram U
J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
[TBL] [Abstract][Full Text] [Related]
3. Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence.
Calonje E; Mentzel T; Fletcher CD
Am J Surg Pathol; 1994 Jul; 18(7):668-76. PubMed ID: 8017561
[TBL] [Abstract][Full Text] [Related]
4. EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall.
Doyle LA; Fletcher CD
J Cutan Pathol; 2011 Sep; 38(9):697-703. PubMed ID: 21752057
[TBL] [Abstract][Full Text] [Related]
5. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
[TBL] [Abstract][Full Text] [Related]
6. Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.
Gleason BC; Fletcher CD
Am J Surg Pathol; 2008 Mar; 32(3):354-62. PubMed ID: 18300816
[TBL] [Abstract][Full Text] [Related]
7. [Cellular fibrous histiocytoma: a clinicopathologic analysis of 27 cases].
Zhong YP; Wang J
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):153-7. PubMed ID: 23769432
[TBL] [Abstract][Full Text] [Related]
8. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
Labonte S; Hanna W; Bandarchi-Chamkhaleh B
J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
[TBL] [Abstract][Full Text] [Related]
9. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
[TBL] [Abstract][Full Text] [Related]
10. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
11. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
Mentzel T; Schärer L; Kazakov DV; Michal M
Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
[TBL] [Abstract][Full Text] [Related]
12. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma.
Mori T; Misago N; Yamamoto O; Toda S; Narisawa Y
J Dermatol; 2008 Jul; 35(7):419-25. PubMed ID: 18705829
[TBL] [Abstract][Full Text] [Related]
13. Fibroblastic connective tissue nevus: a rare cutaneous lesion analyzed in a series of 25 cases.
de Feraudy S; Fletcher CD
Am J Surg Pathol; 2012 Oct; 36(10):1509-15. PubMed ID: 22892597
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
West KL; Cardona DM; Su Z; Puri PK
Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
[TBL] [Abstract][Full Text] [Related]
15. CD34+ pigmented fibrous proliferations: the morphologic overlap between pigmented dermatofibromas and Bednar tumors.
McAllister JC; Recht B; Hoffman TE; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):484-7. PubMed ID: 18806495
[TBL] [Abstract][Full Text] [Related]
16. Test and Teach. Number Ninety: Part 1. Plexiform fibrohistiocytic tumor.
Ng WK; Hlaing TT
Pathology; 1998 Aug; 30(3):257-8, 314-5. PubMed ID: 9770189
[No Abstract] [Full Text] [Related]
17. Angiomatoid features in fibrohistiocytic sarcomas. Immunohistochemical, ultrastructural, and clinical distinction from vascular neoplasms.
Costa MJ; McGlothlen L; Pierce M; Munn R; Vogt PJ
Arch Pathol Lab Med; 1995 Nov; 119(11):1065-71. PubMed ID: 7487409
[TBL] [Abstract][Full Text] [Related]
18. CD34-positive myxoid dermatofibrohistiocytoma of the skin: an indolent post-traumatic tumor that can be mistaken for dermatofibrosarcoma protuberans.
Al-Quran SZ; Russo JJ; Bandarchi-Chamkhaleh B; Hassanein AM
J Cutan Pathol; 2009 Jan; 36(1):84-6. PubMed ID: 19125740
[No Abstract] [Full Text] [Related]
19. IGFBP7, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
Li J; Yu Y; Yang Y; Wang L; Cao J; Liang X; Xiao X; Tu Y; Chen H
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):382-5. PubMed ID: 21492256
[TBL] [Abstract][Full Text] [Related]
20. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
